Bill

Bill > HR6739


US HR6739

Ensuring Seniors’ Access to COVID Treatments Act


summary

Introduced
05/08/2020
In Committee
05/08/2020
Crossed Over
Passed
Dead
12/31/2020

Introduced Session

116th Congress

Bill Summary

To amend title XVIII of the Social Security Act to require coverage under Medicare PDPs and MA-PD plans, without the imposition of cost sharing or utilization management requirements, of drugs intended to treat COVID-19 during certain emergencies. This bill requires prescription drug plans under Medicare and Medicare Advantage to cover drugs that are approved to treat COVID-19 (i.e., coronavirus disease 2019) without cost-sharing during the public health emergency.

AI Summary

This bill requires prescription drug plans under Medicare and Medicare Advantage to cover drugs that are approved to treat COVID-19 (the coronavirus disease 2019) without any cost-sharing for beneficiaries during the public health emergency. Specifically, the bill mandates that these plans must cover all COVID-19 treatment drugs approved or authorized for use, and prohibits them from imposing any prior authorization or other utilization management requirements for these drugs (except for safety-related quantity limits). Additionally, the bill eliminates any deductibles, copayments, coinsurance, or other cost-sharing for COVID-19 treatment drugs during the public health emergency period.

Committee Categories

Business and Industry

Sponsors (1)

Last Action

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (on 05/08/2020)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...